Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT201104106161N1Phase 4Completed
Phase 4, open-label, single-arm trial of plasma-derived factor VIII in hemophilia A, sponsored by Fondazione Angelo Bianchi Bonomi. Primary endpoint: Incidence of factor VIII inhibitors. Started Apr 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT201104106161N1.